Oracle stock falls after report reveals thin margins in AI cloud business
Investing.com -- Zeiss Vision Care has announced an investment in Ocumeda AG, acquiring a 10% stake in the tele-ophthalmology platform at a total company valuation of €100 million.
According to a statement from Fielmann Group AG (ETR:FIE), Zeiss has signed a definitive agreement for the initial stake, with plans to increase its ownership to up to 25% in the future.
The investment comes as part of a strategic plan to scale Ocumeda’s tele-ophthalmology platform in collaboration with Fielmann Group. The partnership aims to expand the reach and capabilities of Ocumeda’s technology in the vision care market.
Ocumeda is recognized as a leading platform in the tele-ophthalmology sector, providing remote eye care services and solutions.
The collaboration between Zeiss Vision Care and Fielmann Group is expected to accelerate Ocumeda’s growth and market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.